TNF and inflammatory bowel disease: Activating serotonin 5-HT2A receptors with (R)-DOI potently blocks TNF-α-induced inflammation in both cell cultures and live animals. The anti-inflammatory effects were confirmed to be receptor-specific, suggesting a promising therapeutic avenue for conditions like atherosclerosis and inflammatory bowel disease.